Sort
64,565 grants matching “drug discovery”
Dissecting the receptor-mediated infection mechanisms of hantaviruses
$501,233Kartik Chandran · Albert Einstein College Of Medicine · R01 · FY2020 · AI
Development and Application of Selective Covalent Cdk7 Inhibitors
$501,164Nathanael Schiander Gray · Dana-Farber Cancer Inst · R01 · FY2016 · CA
'Chemical & Genetic Approaches to Defining & Validating Vulnerable Mycobact Targ
$501,162Eric Joseph Rubin · Texas A&M University · P01 · FY2012 · AI
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2024 · AI
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2022 · AI
Transcriptional Checkpoints Of Autoimmune Encephalomyelitis
$501,155Martha S Jordan · University Of Pennsylvania · R01 · FY2023 · AI
Structural Analysis of Macromolecular Assemblies
$501,153Joachim Frank · Columbia University Health Sciences · R01 · FY2017 · GM
NETs: Protection or Harm in Neonatal Inflammation and Infection
$501,139Christian Con Yost · Utah State Higher Education System--University Of Utah · R01 · FY2025 · HD
A novel, short isoform of the +TIP microtubule (MT) binding protein CLIP170 confers taxane resistance by obstructing the MT pore.
$501,039Paraskevi Giannakakou · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA
Precision Pharmacology and Pharmacovigilance: Leveraging AI to address drug safety knowledge gaps
$501,000Nicholas P Tatonetti · Cedars-Sinai Medical Center · R35 · FY2025 · GM
Chemical intervention of influenza virus RNA nuclear export
$500,998Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R33 · FY2019 · AI
The Pittsburgh Cholestatic Liver Disease Consortium
$500,982Patrick James McKiernan · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · DK
RAD51 Inhibitors for Chemotherapy and Radiation Therapy
$500,963Philip Paul Connell · University Of Chicago · R01 · FY2017 · CA
RAD51 Inhibitors for Chemotherapy and Radiation Therapy
$500,963Philip Paul Connell · University Of Chicago · R01 · FY2016 · CA
RAD51 Inhibitors for Chemotherapy and Radiation Therapy
$500,963Philip Paul Connell · University Of Chicago · R01 · FY2018 · CA
The physiological role of RIPK3-dependent necroptosis
$500,927Andrew Atwell Oberst · University Of Washington · R01 · FY2015 · AI
The Pittsburgh Cholestatic Liver Disease Consortium
$500,894Simon Horslen · University Of Pittsburgh At Pittsburgh · U01 · FY2021 · DK
Genomics
$500,888Daniel Rene Salomon · Scripps Research Institute, The · U19 · FY2014 · AI
Gene Regulation in Memory Circuits as a Consequence of Polysubstance Use
$500,864Karla R. Kaun · Brown University · R01 · FY2024 · DA
Selective C(sp3)-H Oxidations and Functionalizations with Tunable Metal Catalysts for Synthesis
$500,862Maria Christina White · University Of Illinois At Urbana-Champaign · R35 · FY2020 · GM
Novel selective alpha4beta2 nicotinic receptor antagonists for smoking cessation
$500,849Jinhua Wu · Assuage Pharmaceuticals, Inc. · R44 · FY2016 · DA
FOCUSED PARALLEL SYNTHESIS OF DICATION ANTIFUNGAL AGENTS
$500,845University Of North Carolina Chapel Hill · R01 · FY2001 · AI
A Web Service for Fragment-based Selectivity Analysis of Drug Leads
$500,765John Laurence Kulp III · Conifer Point Pharmaceuticals, Llc · R44 · FY2024 · GM
Cellular Image Informatics for Delivery
$500,760Cytoprint, Inc. · R44 · FY2003 · NS
Synthetic biology-regulated RNA vaccines
$500,599Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · EB